Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Regulatory status: BPC-157 is not an approved human medicinal product in any regulatory zone (FDA, EMA, KL)
Introduction: Introduction: AOD-9604 is a synthetic peptide fragment of human growth hormone (hGH 177191) engineered to replicate hGHs fat-metabolism effects without altering IGF-1 or glucose levels. In preclinical research, it promoted lipolysis (fat breakdown) and reduced lipogenesis (fat storage) through receptor-independent mechanisms. AOD-9604 Fast Facts Class: Synthetic hGH fragment analog (Tyr-hGH 177191) Intended purpose: Stimulate fat metabolism while avoiding hGHs growth or glucose effects Mechanism: Increases fat oxidation, enhances lipolysis, suppresses lipogenesis Distinct from hGH: Does not activate the growth hormone receptor or raise IGF-1 Development stage: Completed Phase II trials
BPC-157 has not completed the FDA approval process
Increasing prevalence of metabolic disorders, such as obesity and type 2 diabetes, has significantly fueled the growth of the GLP-1 receptor agonist market
In addition to addressing the deficiency, it is also important to seek professional help if you are experiencing symptoms of depression or anxiety
US$ 28.59
US$ 27.75
US$ 24.98
